These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 12526568

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Axial ligand orientations in a distorted porphyrin macrocycle: synthesis, structure, and properties of low-spin bis(imidazole)iron(III) and iron(II) porphyrinates.
    Patra R, Chaudhary A, Ghosh SK, Rath SP.
    Inorg Chem; 2010 Mar 01; 49(5):2057-67. PubMed ID: 20128598
    [Abstract] [Full Text] [Related]

  • 24. End-on and side-on peroxo derivatives of non-heme iron complexes with pentadentate ligands: models for putative intermediates in biological iron/dioxygen chemistry.
    Roelfes G, Vrajmasu V, Chen K, Ho RY, Rohde JU, Zondervan C, La Crois RM, Schudde EP, Lutz M, Spek AL, Hage R, Feringa BL, Münck E, Que L.
    Inorg Chem; 2003 Apr 21; 42(8):2639-53. PubMed ID: 12691572
    [Abstract] [Full Text] [Related]

  • 25. Cryogenic photolysis of activated bleomycin to ferric bleomycin.
    Burger RM, Usov OM, Grigoryants VM, Scholes CP.
    J Phys Chem B; 2006 Oct 19; 110(41):20702-9. PubMed ID: 17034262
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The orientation of the ligands in iron(III)-bleomycin intercalated with DNA.
    Shields H, McGlumphy C.
    Biochim Biophys Acta; 1984 Aug 21; 800(3):277-81. PubMed ID: 6205696
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The metal bonding domain of the antitumor drug Fe(II)-bleomycin: a DFT investigation.
    Karawajczyk A, Buda F.
    J Biol Inorg Chem; 2005 Jan 21; 10(1):33-40. PubMed ID: 15578242
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Factors affecting the electronic ground state of low-spin iron(III) porphyrin complexes.
    Ikeue T, Ohgo Y, Saitoh T, Yamaguchi T, Nakamura M.
    Inorg Chem; 2001 Jul 02; 40(14):3423-34. PubMed ID: 11421688
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Volume profile analysis for the reversible binding of superoxide to form iron(II)-superoxo/Iron(III)-peroxo porphyrin complexes.
    Dürr K, Jux N, Zahl A, van Eldik R, Ivanović-Burmazović I.
    Inorg Chem; 2010 Dec 06; 49(23):11254-60. PubMed ID: 21058668
    [Abstract] [Full Text] [Related]

  • 37. Electron distribution in iron octaethyloxophlorin complexes. Importance of the Fe(III) oxophlorin trianion form in the bis-pyridine and bis-imidazole complexes.
    Rath SP, Olmstead MM, Balch AL.
    Inorg Chem; 2006 Jul 24; 45(15):6083-93. PubMed ID: 16842017
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.